Bronstein, Gewirtz & Grossman, LLC announces an investigation against Enfusion, Inc. (Enfn) and encourages shareholders to learn more about the examination

New York City, NY / Access Newswire / February 23, 2025 / Bronstein, Gewirtz & Grossman, LLC examines the merger between enfusion, Inc. (“Enfusion”) (NYSE: ENFN) and Clearwater Analytics. Investors who bought enfusion and continue to be kept at the present are encouraged to obtain additional information and support the examination by visiting the company's website: bgandg..com/enfn.

Investigative details

The investigation concerns whether the Board of Directors violates the trustees of the trust agents and did not provide any relevant information to its shareholders before the merger.

On January 13, 2025, Enfusion announced that Clearwater Analytics is acquired in a bar and stock contract worth 1.5 billion US dollars.

What's next?

If you are aware of facts regarding this investigation or the bought enfusion stocks, you can support this investigation by visiting the company's website: bgandg..com/enfn. You can also contact Peretz Bronstein or his customer relationship manager Nathan Miller from Bronstein, Gewirtz & Grossman, LLC: 332-239-2660

There are no costs for you

We represent investors in collective lawsuits on a eventual fee. This means that we will ask the court to refund ourselves for expenses and legal fees, usually a percentage of the entire recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized company that represents investors in collecting lawsuits for securities fraud and shareholder derivative lawsuits. Our company has recovered hundreds of million dollars for investors nationwide.

Follow us to updates to updates too LinkedInPresent XPresent Facebookor Instagram.

Lawyer advertising. Earlier results do not guarantee similar results.

contact

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

See the original press release on Access Newswire